Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality
C. Michael Gibson, MS, MD*,*,
Duane S. Pinto, MD ,
Sabina A. Murphy, MPH*,
David A. Morrow, MD, MPH*,
Hans-Peter Hobbach, MD ,
Stephen D. Wiviott, MD*,
Robert P. Giugliano, MD, SM*,
Christopher P. Cannon, MD*,
Elliott M. Antman, MD*,
Eugene Braunwald, MD* TIMI Study Group
* TIMI Study Chairman's Office, Department of Medicine, Brigham and Women's Hospital, Boston, USA
Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
St. Marienkrankenhaus Siegen, Siegen, Germany
View larger version (20K):
[in a new window]
|
Figure 1 Mortality at 30 days according to baseline creatinine (Cr) and creatinine clearance (CrCl). OR = odds ratio.
|
|
View larger version (14K):
[in a new window]
|
Figure 2 Kaplan-Meier survival curves through two years according to baseline Cr and CrCl. Data available through 30 days only in TIMI-10A and TIMI-14. Abbreviations as in Figure 1.
|
|
View larger version (42K):
[in a new window]
|
Figure 3 Mortality at 30 days according to baseline (A) Cr and (B) CrCl stratified by TIMI risk score (TRS). Abbreviations as in Figure 1
|
|
View larger version (23K):
[in a new window]
|
Figure 4 Mortality at 30 days according to baseline Cr stratified by TRS in patients over the age of 65 years. Abbreviations as in Figures 1 and 3.
|
|
View larger version (39K):
[in a new window]
|
Figure 5 Mortality at 30 days according to baseline (A) Cr and (B) CrCl stratified by history (Hx) of congestive heart failure (CHF) at presentation. Abbreviations as in Figure 1.
|
|
View larger version (39K):
[in a new window]
|
Figure 6 Mortality at 30 days according to baseline (A) Cr and (B) CrCl stratified by Killip class at presentation.
|
|
|
